Search

everythinglearnresearchcommunity

for

Search:↓

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

Tofacitinib is an effective and safe treatment for alopecia areata.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Intralesional triamcinolone acetonide is better than PRP for treating scalp alopecia areata, leading to faster and more complete hair regrowth.

A young girl with skin and scalp conditions showed some improvement with treatment.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

A child's hair loss after Kawasaki disease may help understand the disease's autoimmune causes.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.

People with Alopecia Areata and Androgenic Alopecia have more mast cells in their scalp than healthy individuals, especially those with Alopecia Areata.

Alopecia patients have more mast cells in their scalps, especially in severe cases and older age, with alopecia areata showing the highest increase.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Dermoscopy is a useful tool for diagnosing and managing alopecia areata.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Ischemic modified albumin could be a new indicator of oxidative stress in people with alopecia areata.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

The excimer lamp is a safe and effective treatment for severe alopecia areata.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.